Biogen (BIIB) EBT Margin (2009 - 2026)
Biogen's EBT Margin was -0.32% in Q3 2026, down 22.31 percentage points from 21.99% a year earlier and down 5.16 percentage points from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) EBT Margin (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Biogen's EBT Margin was 4.32% through Sep 30, 2026, down 14.59 percentage points year-over-year; for FY2025, it was 15.74%, down 3.96 percentage points from FY2024.
- EBT Margin shows a five-year change of -21.81 percentage points (FY2020 to FY2025).
- In earlier years, EBT Margin was 19.70% in FY2024 (+6.51 pp), 13.18% in FY2023 (-22.12 pp), 35.31% in FY2022 (+19.41 pp) and 15.89% in FY2021 (-21.65 pp).
- Quarterly EBT Margin has moved between -5.58% (Q3 2023) and 54.66% (Q3 2022) over five years.
- Compared with a year earlier, EBT Margin was higher in two of the last eight quarters, with an average year-over-year change of -7.73 percentage points.
- The best year-over-year quarter for EBT Margin over five years was Q3 2022 (a gain of 44.18 percentage points); the worst was Q3 2023 (a drop of 60.24 percentage points).
- Per Business Quant data, BIIB's EBT Margin in the three quarters before Q3 2026 was 4.84% (Q2 2026), 15.24% (Q1 2026) and -2.46% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 26.27% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 20.41% |
| 10 | Biogen | 37.46 Bn | 26.77 Bn | 2.06 Bn | -0.32% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -0.32% |
| Jun 30, 2026 | 4.84% |
| Mar 31, 2026 | 15.24% |
| Dec 31, 2025 | -2.46% |
| Sep 30, 2025 | 21.99% |
| Jun 30, 2025 | 28.12% |
| Mar 31, 2025 | 12.80% |
| Dec 31, 2024 | 11.88% |
| Sep 30, 2024 | 18.29% |
| Jun 30, 2024 | 28.35% |
| Mar 31, 2024 | 20.29% |
| Dec 31, 2023 | 12.22% |
| Sep 30, 2023 | -5.58% |
| Jun 30, 2023 | 28.83% |
| Mar 31, 2023 | 17.80% |
| Dec 31, 2022 | 23.73% |
| Sep 30, 2022 | 54.66% |
| Jun 30, 2022 | 49.03% |
| Mar 31, 2022 | 13.72% |
| Dec 31, 2021 | 14.81% |
API Access
Biogen EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();